All Comments by John Trojanowski
- Continuous CSF drainage in AD: results of a double-blind, randomized, placebo-controlled study.
- A Blood Test for AD?
- Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements.
- Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson's disease.
- RNA-binding proteins hnRNP A2/B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a Drosophila model of FXTAS.
- CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study.
- Detecting antigens by quantitative immuno-PCR.
- PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis.
- Three weeks of running wheel exposure improves cognitive performance in the aged Tg2576 mouse.
- Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B.
- Oligomeric alpha-synuclein inhibits tubulin polymerization.
- Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees.
- Alzheimer's researchers open the doors to data sharing.
- Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model.
- TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.